Retroviral capsid protein (CA) mediates protein interactions driving the assembly of both immature viral particles and the core of the mature virions. Structurally conserved N-terminal domains of several retroviruses refold after proteolytic cleavage into a beta-hairpin, stabilized by a salt bridge between conserved N-terminal Pro and Asp residues. Based on comparison with other retroviral CA, we identified Asp50 and Asp57 as putative interacting partners for Pro1 in Mason-Pfizer monkey virus (M-PMV) CA. To investigate the importance of CA Pro1 and its interacting Asp in M-PMV core assembly and infectivity, P1A, P1Y, D50A, T54A and D57A mutations were introduced into M-PMV. The P1A and D57A mutations partially blocked Gag processing and the released viral particles exhibited aberrant cores and were non-infectious. These data indicate that the region spanning residues Asp50-Asp57 plays an important role in stabilization of the beta-hairpin and that Asp57 likely forms a salt-bridge with P1 in M-PMV CA.

Gilead Sciences and IOCB Research Centre Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Abdurahman S, Youssefi M, Hoglund S, Vahlne A. Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity. Retrovirology. 2007;4:69. PubMed PMC

Auerbach MR, Brown KR, Singh IR. Mutational analysis of the N-Terminal domain of Moloney murine leukemia virus capsid protein. J. Virol. 2007;81:12337–12347. PubMed PMC

Bouamr F, Cornilescu CC, Goff SP, Tjandra N, Carter CA. Structural and dynamics studies of the D54A mutant of human T cell leukemia virus-1 capsid protein. J. Biol. Chem. 2005;280:6792–6801. PubMed

Brody BA, Hunter E. Mutations within the env gene of Mason-Pfizer monkey virus: effects on protein transport and SU–TM association. J.Virol. 1992;66:3466–3475. PubMed PMC

Campos-Olivas R, Newman JL, Summers MF. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J. Mol. Biol. 2000;296:633–649. PubMed

Cornilescu CC, Bouamr F, Yao X, Carter C, Tjandra N. Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein. J. Mol. Biol. 2001;306:783–797. PubMed

Forshey BM, von Schwedler U, Sundquist WI, Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 2002;76:5667–5677. PubMed PMC

Gamble TR, Yoo SH, Vajdos FF, vonSchwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 1997;278:849–853. PubMed

Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, Sundquist WI, Hill CP. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 1996;87:1285–1294. PubMed

Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI. Assembly properties of the human immunodeficiency virus type 1 CA protein. J. Virol. 2004;78:2545–2552. PubMed PMC

Ganser-Pornillos BK, Cheng A, Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell. 2007;131:70–79. PubMed

Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, Sundquist WI. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 1996;273:231–235. PubMed

Gross I, Hohenberg H, Huckhagel C, Krausslich HG. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 1998;72:4798–4810. PubMed PMC

Jin Z, Jin L, Peterson DL, Lawson CL. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J. Mol. Biol. 1999;286:83–93. PubMed

Khorasanizadeh S, Campos-Olivas R, Summers MF. Solution structure of the capsid protein from the human T-cell leukemia virus type-I. J. Mol. Biol. 1999;291:491–505. PubMed

Kingston RL, Fitzon-Ostendorp T, Eisenmesser EZ, Schatz GW, Vogt VM, Post CB, Rossmann MG. Structure and self-association of the Rous sarcoma virus capsid protein. Struc. Fold. Des. 2000;8:617–628. PubMed

Leschonsky B, Ludwig C, Bieler K, Wagner R. Capsid stability and replication of human immunodeficiency virus type 1 are influenced critically by charge and size of Gag residue 183. J. Gen. Virol. 2007;88:207–216. PubMed

Momany C, Kovari LC, Prongay AJ, Keller W, Gitti RK, Lee BM, Gorbalenya AE, Tong L, McClure J, Ehrlich LS, Summers MF, Carter C, Rossmann MG. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 1996;3:763–770. PubMed

Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, Taylor IA. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature. 2004;431:481–485. PubMed

Mortuza GB, Dodding MP, Goldstone DC, Haire LF, Stoye JP, Taylor IA. Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, Gag assembly and core formation. J. Gen. Virol. 2008;376:1493–1508. PubMed

Nandhagopal N, Simpson AA, Johnson MC, Francisco AB, Schatz GW, Rossmann MG, Vogt VM. Dimeric Rous sarcoma virus capsid protein structure relevant to immature Gag assembly. J. Mol. Biol. 2004;335:275–282. PubMed

Newman RM, Hall L, Connole M, Chen GL, Sato S, Yuste E, Diehl W, Hunter E, Kaur A, Miller GM, Johnson WE. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5{alpha} Proc. Natl. Acad. Sci. U. S. A. 2006;103:19134–19139. PubMed PMC

Parker SD, Hunter E. Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro. Proc. Natl. Acad. Sci. U. S. A. 2001;98:14631–14636. PubMed PMC

Pettit SC, Henderson GJ, Schiffer CA, Swanstrom R. Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease. J. Virol. 2002;76:10226–10233. PubMed PMC

Rayne F, Bouamr F, Lalanne J, Mamoun RZ. The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation. J. Virol. 2001;75:5277–5287. PubMed PMC

Rumlova M, Ruml T, Pohl J, Pichova I. Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection. Virology. 2003;310:310–318. PubMed

Rumlova-Klikova M, Hunter E, Nermut MV, Pichova I, Ruml T. Analysis of Mason-Pfizer monkey virus gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape. J. Virol. 2000;74:8452–8459. PubMed PMC

Stansell E, Apkarian R, Haubova S, Diehl WE, Tytler EM, Hunter E. Basic residues in the Mason-Pfizer monkey virus Gag matrix domain regulate intracellular trafficking and capsid-membrane interactions. J. Virol. 2007;81:8977–8988. PubMed PMC

Strambio-de-Castillia C, Hunter E. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 1992;66:7021–7032. PubMed PMC

von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, Sundquist WI. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. Embo. J. 1998;17:1555–1568. PubMed PMC

von Schwedler UK, Stray KM, Garrus JE, Sundquist WI. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 2003;77:5439–5450. PubMed PMC

Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein

Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation

Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site

Stabilization of the β-hairpin in Mason-Pfizer monkey virus capsid protein- a critical step for infectivity

In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV